GL1X · GenesisL1 explorer

Research workbench

Crystal structure of pdgfra in complex with imatinib by co- crystallization

Analyse Crystal structure of pdgfra in complex with imatinib by co- crystallization in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6JOL
Type
protein
Length
279 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Platelet-derived growth factor receptor alpha
EC
2.7.10.1
UniProt
P16234
Ligands
STI
Pockets
1 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APlatelet-derived growth factor receptor alpha (EC 2.7.10.1)protein27939% helix, 19% strandP16234

Ligands and binding sites

  • STI · 4-(4-methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15720.740.8160STI

Compared structures

  • 6JOL · Crystal structure of PDGFRA in complex with imatinib by co-crystallization · the same entry in another collection · chain A against A, TM-score 1.00
  • P16234 · AlphaFold monomer V2.0 prediction for platelet-derived growth factor receptor alpha… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.